RE: Accustem1 Apr 2021 14:12
Plan2Retire
Foralumab has not started Phase2 trials as yet which needs to be successful then phase 3 I think once the MHRA , FDA and the EMA approve our drug then we should get some real income and the SP will climb rapidly